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Nephrotoxicity
Abstracts of Poster Session
Multiple Mechanisms are Involved in Cellu-
lar Response to Cadmium: Metallothionein
Gene Organization and Regulation and
Other Factors. C. E. HILDEBRAND, B.D. CRAW-
FORD, M. D. ENGER, B. B. GRIFFITH, J. K. GRIF-
FITH, J. C. SEAGRAVE, J. G. TESMER, R. A. TOBEY
and R. A. WALTERS, Genetics and Toxicology
Groups, LosAlamosNationalLaboratory, LosAl-
amos, NM87545.
Combined mammalian somatic cell and molecular genetics
approaches havebeen used todefine mechanisms which modu-
late cellular sensitivity or resistance to cadmium (Cd). A
series of cadmium-resistant (Cdr) clonal cell lines has been
derived from the Cd-sensitive (Cds) Chinese hamster (CHO)
cell. These cell lines display threshold levels forCdCl2 toxicity
ranging from 0.2 jM (Cds CHO cell) to 200 jM (Cdr200T1 cell)
in monolayer culture.
A major factor in expression of the Cdr phenotype is the
ability of cells to induce synthesis of metallothionein (MT).
The Cds CHO cell does not produce detectable MT in the
absence or presence of Cd2+. Conversion of the CHO cell to
Cdr cell line correlates with a switch from noninducibility to
inducibility of MT synthesis. Theatment of CHO cells with a
DNA hypomethylating agent (5-azacytidine) increased the
frequency of a phenotype switch from Cd sensitivity to Cd
resistance. Molecular genetic analyses ofgenomic DNAs from
Cds and Cdr cells using molecularly cloned cDNA sequences
encoding Chinese hamster MTI and MTII confirmed that the
switch from MT noninducibility to MT inducibility involves
changes in the pattern of DNA methylation in the region of
the MT genes.
Increased levels ofCd-resistance are related to overproduc-
tion ofMT. Molecular genetic analyses ofgenomic DNAs from
both CHO and the sublines resistant to high Cd concentra-
tions revealed coordinate amplification of both MTI and II
genes up to 14-fold above the number ofMT gene copies in the
Cds CHO cell.
In addition to the involvement of the MT gene family in
cellular responsiveness to heavy metals, other domains of
cellular response have been identified. These domains include
altered thiol metabolism following cellular Cd exposure as
well as modulation ofexpression ofmultiple cytoplasmic non-
MT proteins. Studies of the roles of these responses in Cd
metabolism are in progress.
The Use of a Metallothionein I cDNA Probe
for Quantitating Changes in MT-1 mRNA
Levels in Maternal and Fetal Tissues of the
Mouse. C. J. QUAIFE, and N. K. MOTTET, Depart-
ment ofPathology, University ofWashington, and
D. M. DURNAM and R. D. PALMITER, Department
ofBiochemistry, University ofWashington, Seattle
98195.
Metallothionein (MT) protein levels are elevated in the fetal
liver. Tb study the mechanism ofits induction, we prepared a
cDNAprobe to monitorchanges in MT-1 levels.Tb prepare the
probe, cloned sequences containing the coding region for MT-1
were nick-translated in the presence of 32P-deoxynucleotides
and the strands separated chromatographically to yield a
single-stranded cDNA. MT-1 mRNA levels were measured in
a solution hybridization assay in which the labeled cDNA
anneals with MT-1 mRNA present in a total nucleic acid
sample. As little as 0.5 pg mRNA can be detected within a day
oftotal nucleic acid isolation.
We examined the temporal relationship between changes in
the levels of plasma corticosterone, induction of fetal MT-1
mRNA and changes in zinc and copper concentrations. Our
results show that fetal liver MT-1 mRNA levels become ele-
vated during gestation (peaking on day 18) and that changes
in concentration are predicted by changes in maternal and
fetal plasma corticosterone levels. Placenta, maternal kidney
and fetal kidneys (examined on day 18) did not respond
similarly. Zinc was bound to fetal liver MT during the early
induction phase, however, Cu became the predominant metal
associated with MT at later times.
As a working hypothesis, we propose that corticosterone
induces MT-1 mRNA in fetal liver and that resulting MT
initially binds Zn which is subsequently displaced by copper.
Characterization of Bismuth- And Mercury-
Induced Metallothioneins, J. A. SZYMANSKA*,
M. J. STILLMAN, A. J. ZELAZOWSKI and J. K.
PIOTROWSKI,DepartmentofToxicological Chemis-
try MedicalAcademy, Lodz, Poland.
We have shown previously that metallothioneinlike pro-
teins can be isolated from rat livers and kidneys following
injections ofbismuth and mercury.Optical absorption, circular dichroism, magnetic circular
dichroism and emission spectra havebeenobtainedforhepatic
and renal proteins isolated after exposures ofrats to BiCl3 and
HgCl2. Our results suggest that the liver proteins are zinc
metallothioneins, whereas the renal MTs contain copper and
metal-stimulator.
Spectroscopic Studies of the Metal Binding
Sites in Metallothioneins. A. Y. C. LAW, J. A.
SZYMANSKA and M. J. STILLMAN, Department of
Chemistry, The University of Western Ontario,
London, Canada, N6A 5B7.
Optical absorption, circular dichroism, magnetic circular
dichroism and emission spectra have been obtained from a
variety of Cd,Zn and Cd,Cu-metallothioneins. These data
arise from chromophores at the metal ion binding sites in the
MT and allow a view of chemical changes that take place at
these binding sites.
Metal Substitution in Metallothioneins. A. Y.
C. LAW, J. A. SZYMANSKA and M. J. STILLMAN,
Department ofChemistry, The University ofWest-
ern Ontario, London, Canada, N6A 5B7.
Substitution of the cadmium and zinc in Cd, Zn-MT with
copper, mercury, cadmium and silver results in well-defined
spectral changes. These can be associated with the initial
direct replacement ofthe zinc, followed by replacement ofthe
cadmium. Finally, at higher concentration, metal binding
results in the loss of the stereochemical arrangement of sul-
fide-containing groups in the binding sites that is observed in
the native protein.
Physicochemical and Metabolic Properties
of Modified Metallothioneins. D. M. TEMPLE-
TON and M. G. CHERIAN, Department ofPathol-
ogy, University of Western Ontario, London, On-
tario, CanadaN6A 5C1.
The biocomplexes of cadmium may play an important role
in the tissue deposition and toxicity ofthis metal. Injection of
experimental animals with Cd2+ salts results in major deposi-
tion of Cd initially in the liver, whereas injected Cd-metal-
lothionein (Cd-MT) is accumulated mainly in the renal tu-
bules. Various organic chelates of Cd show an intermediate
pattern of distribution. In order to better understand the
factors controlling thebinding ofmetals to MT, and Cd deposi-
tion and toxicity, we are investigating modified MTs as novel
chelators ofCd.
Two distinct chemically crosslinked Cd-MT polymers have
beenprepared from rat liverCd-MT-II. An octamer ofMT (GA-
MT) with a molecular weight of 53,000 was prepared by
reaction with glutaraldehyde followed by NaBH4 reduction.
The polymerization resulted in modification of seven of nine
lysine residues, but unaltered thiol content as shown by amino
acid analysis and mercurial titrations. However, two of the
tetracoordinate Cd binding sites (per monomer) were lost,
indicating altered binding cluster geometry. The isoelectric
point ofGA-MT is increased to 5.2 from that ofmonomer (4.6).
By reaction with dimethyl suberimidate, polymers (DMS-MT)
have been prepared with molecular weights up to 100,000.
DMS-MT has an unchanged isoelectric point (4.6) and similar
Cd binding sites to MT, with modifications offour lysines per
monomer. Both types ofpolymer have lower frictional coeffi-
cients than the monomer. Phenyl mercuric derivatives ofMT-
II, GA-MT, and DMS-MT were prepared, which resulted in
opening of the metal binding clusters. At phenyl mercuric
substitution often or more thiols per monomer, all species are
insoluble at their pI. Biphasic reactivity of the thiols with
DTNB was observed for all species, which is consistent with
proposed metal cluster structures.
When polymers labeled with 109Cd are injected IV into rats,
they stay in circulation longer than any other known soluble
complex of Cd. A unique, uniform tissue distribution of Cd
from the polymer was observed. The modifications ofMT can
affect both its metal binding properties and the metabolic fate
ofCd.
Effects of N,N-Disubstituted Dithiocarba-
mates on Distribution and Excretion of Cad-
mium (Cd). G. R. GALE, VeteransAdministration
Medical Center, and Department of Pharmacol-
ogy, Medical University of South Carolina,
Charleston, SC 29403, E. M. WALKER, JR., De-
partment of Laboratory Medicine, Medical Uni-
versity ofSouth Carolina, Charleston, SC 29403
and M. M. JONES, Department ofChemistry and
Center in Toxicology, Vanderbilt University,
Nashville, TN37235.
N,N-Diethyldithiocarbamate (DEDC) is an antagonist of
the acute toxicity ofCdCl2 in mice and is more effective than
diethylenetriaminepentaacetate (DTPA) or dimercaptosucci-
nate (DMSA) inmobilizing Cd from its metallothionein-bound
sites in liver, kidney and spleen. However, it promotes moder-
ate elevations of Cd in lung, testes and heart, and over a 10-
fold increase in brain Cd levels. The redistribution to brain
has been attributed to a high octanol/water partition coeffi-
cientofthe Cd complex with DEDC, Cd(DEDC)2, which has no
polar group. Consequently, N,N-dihydroxyethyldithiocarba-
mate (DHDC) and N,N-dicarboxymethyldithiocarbamate
(DCDC) were synthesized and compared with DEDC for rela-
tive efficacies in mobilizing Cd from various tissues. DHDC
effectively mobilized Cd from liver, kidney, and spleen, while
not promoting its accumulation in lung, testes, heart, or
brain. The DCDC was totally ineffective. DHDC also pro-
moted Cd mobilization from bone. Unlike DEDC, which pro-
motes accumulation ofCd in skin and muscle, DHDC signifi-
cantly reduced Cd levels in those tissues. The relative
efficacies of the three analogs in reducing whole-body 109Cd
burden were DEDC > DHDC > DCDC. Mobilization and
excretion ofCdby these chelators were closely correlated with
the octanol/aqueous partition coefficients of the Cd-chelator
complexes.
Effects ofNiCl2TreatmentonMetallothionein
Concentrations in Rat Liver and Kidney.
F. W. SUNDERMAN, JR. and C. FRASER, Depart-
ments ofLaboratory Medicine andPharmacology,
Univesity ofConnecticut School ofMedicine, Far-
mington, CT 06032.
The effects of NiCl2 treatment upon metallothionein (MT)
concentrations were studied in livers and kidneys ofgroups of
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fiveto eightmale Fischer-344 rats, based upon MT-analysis by
the Cd saturation-hemolysate procedure of Onosaka and
Cherian. At 6.5 hr after an injection ofNiCl2 (0.75 jmole/kg,
SC), MT concentrations averaged 125 ± 49 gg/g in liver and
174 ± 32 jg/g in kidney, (p < 0.02 vs. corresponding values of
49 ± 15 and 136 ± 6 in vehicle controls). At 17 hr after
injection of NiCl2 (0.75 tmole/kg, SC), MT concentrations
averaged 318 ± 58 gg/g in liver and 276 ± 75 gg/g in kidney,
(p < 0.001 vs. corresponding values of39 ± 10 and 120 ± 8 in
vehicle controls). Dose-effect relationships were observed for
NiCl2-stimulation of MT concentrations in liver and kidney.
For example, at 17 hr after intermediate NiCl2 dosages (0.25
and 0.50 jimole/kg, SC) MT concentrations averaged 156 ± 38
and 226 ± 23 gg/g in liver, and 239 ± 49 and 246 ± 32 gg/g in
kidney (p < 0.001 vs. vehicle controls). Induction of MT
concentrations in liver and kidney at 17 h after NiCl2 treat-
ment (0.25 gmole/kg, SC) was not prevented by IP actinomy-
cin D (0.5 mg/kg at 18 hr, 0.25 mg/kg at 16 hr, and 0.25 mg/kg
at 14 hrbefore death). Repeated administration ofNiCl2 (0.10
jmole/kg, IP, on four successive days, with sacrifice 3 days
after the lasttreatment) caused slightly increased MT concen-
trations (MT = 66 ± 19 gg/g in liver and 175 ± 30 in kidney
ofNiCl2 rats, (p < 0.05 vs. corresponding values of46 ± 9 and
138 ± 23 in vehicle controls). At the same dosage and treat-
ment schedule, CdCl2 produced greatly increased MT concen-
trations (liver MT = 752 + 226 jg/g; kidney MT = 428 + 169
lig/g).
Is Cadmium Released from Metallothionein
in Kidneys Preserved for 'lransplantation?
C. G. ELINDER, B. PALM and M. PISCATOR,Depart-
mentofEnvironmentalHygiene, KarolinskaInsti-
tute, and TheNationalInstitute ofEnvironmental
Medicine, S-104 01 Stockholm, Sweden, G. LUND-
GREN, Department of Transplantation Surgery,
HuddingeHospital, S-141 86Huddinge, Sweden,
and M. NORDBERG, Department ofEnvironmental
Medicine, Umea University, S-901 87 Umea, Swe-
den.
Thirteen rabbits were given repeated cadmium injections to
achieve cadmium concentrations in kidney cortex ranging
from 0.05 to 1 imole Cd/kg wet weight. Another four animals
served as controls. One kidney from each animal was frozen
directly to -70°C, whereas the other kidney was kept for 24
hr at ±0°C in a preservative (Sachs' solution) to simulate
conditions for preservation of human donor kidneys before
transplantation. Protein binding ofcadmium, zinc, and copper
in kidney homogenates and the concentration ofmetallothio-
nein (MT) was measured in the kidney that was frozen di-
rectly and in the kidney that had been preserved.
No gross differences in the protein binding ofcadmium, zinc
and copper or in the metallothionein content were seen be-
tween the directly frozen and preserved kidneys from the
same animal. This indicates that MT is not rapidly broken
down in rabbit kidneys which have been preserved similarly
to human donor kidneys 24 hr prior to a transplantation in a
proper standard preservation solution.
Uptake and Distribution ofCadmium in Rats
Intubated with Rat and Crab Metallothio-
neins. M. A. WIEDOW andJ. M. FRAZIER, Division
of Toxicology, School of Hygiene and Public
Health,JohnsHopkins University,Baltimore, MD
21205.
The role of different animal metallothioneins (MT) and
cadmium (Cd) concentrations on the uptake and distribution
ofCd in rats was studied. Adult male (500-600 g) Wistar rats
(N = 24) were divided into four exposure groups. Animals
were maintained in metabolic cages and fed acd libitum. Each
group was intubated with 3 mL of a 0.9% saline solution
containing cadmium and 109Cd tracer. The first three groups
were given 60 ig Cd either in the ionic salt form (0.5 pCi) or
one ofthe Cd-bound proteins (crab MT, 0.5 giCi; rat MT-II, 0.2
pCi). Animals were sacrificed by exsanguination 24 hr after
exposure. Urine, feces, target (liverandkidney) andnontarget
tissues (lung, heart, pancreas, spleen, bone, muscle, testis,
blood and washed intestine and stomach) were monitored for
109Cd activity. There were detectable levels of 109Cd in target
tissues, but >98% ofthe activity was confined to the intestine,
digested material and feces. Cd was not detected in the urine
or any ofthe nontarget tissues. The average uptake ofCd from
the metal-bound crab and rat protein groups were 0.13 and
0.11%, respectively. However, the uptake in the ionic salt
treated animals were 1.35% for the 60 gig Cd exposure and
0.05% in the low Cd-dosed group. The kidneys from the MT-
exposed animals contained 41.0 + 4.6 (crab) and 46.3 + 4.5%
(rat) ofthe administered Cddose, butonly 9.0± 1.3% ofthe Cd
distribution was located in this tissue for the high dosed Cd
rats. The low dose Cd exposure group had 24.1 ± 6.6% ofthe
absorbed activity in the kidney. These data indicate that a
highdose ofionic Cd is more rapidlytakenupbythe gut inthe
rat, but Cd presented in a low dose or especially as MT may
influence the distribution of the metal towards the kidneys.
Further studies on intermediate doses of Cd are presently
being conducted.
A Case-Control Study ofEnvironmental Fac-
tors and Chronic Renal Failure. D. P.
SANDLER, National Institute of Environmental
Health Sciences, Research Triangle Park, NC
27709.
There are currently more than 50,000 individuals in the
U.S. on maintenance dialysis for end-stage renal disease at a
cost ofmore than $1.5 billion peryear. Individuals on dialysis
represent only part ofthe population with chronic renal fail-
ure. Chronic renal failure (CRF) is a significant public health
problem, but its etiology is poorly understood. Epidemiologic
study of CRF has been made difficult by lack of uniform
criteria for diagnosis or classification ofpatients. In addition,
chronic renal failure often develops slowly over a number of
years, making it difficult to recognize, in retrospect, an etio-
logic agent or agents.
A number of environmental agents have been implicated,
nonetheless, in the etiology of CRF. These include lead, cad-
mium, analgesicdrugs and solvents. For some ofthese factors,
the evidence is fairly convincing that they play a role in the
development of CRF. For others, the evidence is less well
documented. Fewcontrolled studiesoftheroleofanypotential
risk factors in accounting for CRF incidence has yet to be
determined.
Our study will evaluate the role ofenvironmental factors in
the etiology of chronic renal failure. Using a case-control
interview approach, we will determine the frequency with
which certain exposures occur prior to the development of
CRF and compare the frequency ofsuch exposures to that in
individuals without renal disease. We intend to evaluate the
293relative importance ofsuspected renal disease riskfactors and
to examine interactions between exposures. By including a
wide range of CRF patients in the study, we will be able to
examine whether risk patterns vary with disease severity or
with histopathologic diagnosis.
Saturation Analysis and Copper Displace-
ment Studies on the Binding Site of the Cad-
mium-binding Protein from the American
Oyster (Crassostrea virginica). P. MISTRY, C. L.
CZOP, D. P. ELLIOTT, C. F. CHIGNELL and B. A.
FOWLER. National Institute of Environmental
Health Sciences. Research Triangle Park, NC
27709.
Previous studies have shown that the American oyster
(Crassostrea virginica) produces a low molecular weight cad-
mium-binding protein (CdBP) similar in size to metallothio-
nein (MT) but which contains less cysteine and binds only 1-2
g-atoms Cd/mole protein. Scatchard analysis of109Cd binding
to purified CdBP showed a single class of site(s) with an
apparent dissociation constant (Kd) of10 -7M for Cd. Addition
of5,5-dithiobis-(2-nitrobenzoic acid) (DTNB) to CdBPfollowed
by separation of protein bound and free ionic Cd on small
Sephadex G-25 columns demonstrated displacement of Cd
from CdBP. A variable SH:Cd ratio of 4.5:1 to 2:1 for CdBP
depending upon Cd saturation status instead of the 3:1 ratio
reportedforMT wasdetermined bythis method. Incubation of
CdBP with EDTA (1.3 mM) showed little release of Cd from
the protein except when DTNB wasadded. Circular dichroism
studies ofCdBP incubated in vitro with a 2-fold excess ofCd or
Cu disclosed marked reduction in the positive 259 nm Cd-S
bondpeak but no changes in otherportionsofthe spectrum. In
addition, CdBP isolated from oysters collected in areas with
greater human activity and possessing higher tissue burdens
of Cu from in vivo exposure showed similar circular dichroic
properties. These studies suggest that the lower Cd-binding
affinity of CdBP relative to MT stems from the presence of
only 2 SH groups per Cd at saturation, but that like MT these
groups inhibit EDTA chelation ofCd from the protein. Addi-
tion of excess Cd or Cu resulted in the formation of an
optically less active complex, at 259 nm.
Metal-binding Proteins in the American Oys-
ter: Effects of Cadmium and Copper. D. W.
ENGEL, National Marine Fisheries Service,
NOAA, Southeast Fisheries Center, Beaufort La-
boratory, Beaufort, NC28516.
The American oyster, Crassostrea virginica, has a demon-
strated ability to accumulate trace metals such as copper,
cadmium and zinc to very high concentrations without detect-
able physiological changes. This mollusc also produces copper
and cadmium-binding proteins when exposed to these metals
under laboratory conditions. In the current set of experie-
ments oysters were: (Experiment 1) exposed to cadmium, 0.1
ppm, for 4 weeks and then allowed to depurate for 4 weeks in
the absence of cadmium and (Experiment 2), exposed to cad-
mium and copper, 0.1 and 0.025 ppm for 4 weeks and then
allowed to depurate for4weeks inthe absence ofcadmium but
in the presence of elevated copper. Exposed oysters were
sampled weekly for 8 weeks and analyzed for total copper,
cadmium and zinc, and intracellular metal-binding proteins.
Total metals were analyzed by atomic absorption spectropho-
tometry and the metal-binding proteins were separated on
Sephadex G-75 gel-filtration media. In Experiment 1, cad-
mium displaces copper from the metal-binding proteins dur-
ing the accumulation phase and in Experiment 2, copper
displaced cadmium during the depuration phase. From mass
balance calculations the percentage ofthe oyster cadmium on
the metal-binding proteins ranged from 25 to 50% in Experi-
ment'l and from 12 to 60% in Experiment 2, but the forcing
functions and time courses were different. The percentage of
protein bound copper, however, in both experiments was about
30% throughout the experiments. Further, mass balance
equations indicate that the metal-binding proteins in the
oysters are primarily copper proteins that can be activated by
elevated levels ofcadmium.
Monoclonal Antibodies to Metallothionein
from Cd2+-Resistant Chinese Hamster Lung
Fibroblasts. T. MASuI and T. UTAKOJI, Depart-
ment of Cell Biology, Cancer Institute, Toshima-
ku, Tokyo 170, Japan, and M. KIMURA, Depart-
ment of Experimental Toxicology, National
Institute of Industrial Health, Tama-ku, Kawa-
saki 213, Japan.
Four monoclonal antibodies of the mouse against metal-
lothionein-2 (MT-2) from Cd-resistant fibroblasts of the Chi-
nese hamster lung (Cdr-CHL) have beenprepared. Each one of
the antibodies showed a unique reactivity pattern against
MTs ofseveral mammals. Onthe contrary, polyclonal antisera
of rabbit against native or polymerized mouse liver MT-2
showed general cross-reactivity.
Reactivities of MTs with these monoclonal antibodies were
affected by amino acid sequence, metal composition and other
factors, such as the presence of 3-mercaptoethanol.
Monoclonal antibodies will give us detailed information on
the three-dimensional molecular configuration of the metal-
lothioneins in various conditions.
ble 1.
Metallothionein ACM-la ACM-2a ACM-3a ACM-4a C-la C-2a C-3a
Cdr-CHL MT-1 + - + - + + +
MT-2 + + + + + + +
Mouse-liver MT-1 + - + - + + +
(Cd-induced) MT-2 + + + - + + +
Rat-liver MT-l + - - + + + +
(Cd-induced) MT-2 + + + + + + +
Rat-liver MT-1 + - - - + + +
(Zn-induced) MT-2 + - - + + + +
aACM = ascitic fluids ofmouse hybridomas; C = conventional antiserum ofrabbit against mouse MT-2.
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Monoclonal Antibodies to Metallothionein
from Cd2+-Resistant Chinese Hamster Lung
Fibroblasts. M. KIMURA, T. MASUI and T. UTA-
KOJI,NationalInstitute ofIndustrialHealth, Min-
istry ofLabour, Tama-ku, Kawasaki 123, Japan.
Four monoclonal antibodies of the mouse against metal-
lothioneins (Mts) from CD2x-resistant fibroblasts ofthe Chi-
nese hamster lung (Cd-CHL) have been prepared. Each one of
the antibodies showed a unique cross-reactivity pattern when
tested against MT from the livers of several mammals and
from yeast.
Effect of Chelating Agents on Cadmium Re-
tention in Lung, Liver and Kidney of Rats
After Inhalation Exposure. Y. H. LEE and G.
OBERDOERSTER,Division ofToxicology, University
ofRochester, Rochester, NY 14642.
Some chelating agents such as BAL and EDTA have been
shown to reduce the mortality in animals with increased
nephrotoxicity of Cd. Therefore, an increase in kidney Cd
levels after chelating agent treatment should be avoided.
Thus, we studied the effectiveness ofBAL and DMPS given by
different routes on mobilizing Cd in body organs after inhala-
tion exposure of Cd. In all studies, Long-Evans male rats
weighing 185-225 g (10 rats per group) were used and they
were exposed to 1o9CdCl2 in a nose-only system. In the first
experiment, BAL was given IP, 50 mg/kg/day in 1 mL propyl-
ene glycol, 5 days per week for 2 weeks, starting immediately
afterexposure to 38gg/m3 109CdCl2 for 1 hr. The controls were
injected IP with 1 mL/kg propylene glycol. In the second
experiment, rats were treated with 500 jimole/kg/day DMPS,
IP in 2 mL saline, 5 days per week for 2 weeks after exposure
to 128 gig/m3 1o9CdCl2 for 90 min. The controls were given 2
mL/kg saline only. Neither of the treatments decreased the
bodyburden ofCd onthe basis ofinvivo thoracic counts. Also,
Cd distribution in lung, liver and kidney was not altered by
these treatments. In the third experiment, rats were treated
by nose only exposure to 250 mg/m3 DMPS for 30 min per day
for 14days after1o9CdCl2 exposure to 90 ig/M3 for 90 min. The
controls were sham-exposed in nose-only tubes for 30 min
daily. Liver Cd increased significantly, twice as much as that
of the controls. Cd content in the lung also decreased. The
amount of Cd decrease in the lung is almost equal to the Cd
increase in the liver of the treatment group. Cd levels in
kidneys ofthe treated rats did not differ from that ofcontrols.
In order to find out whether this was an early or late effect of
Cd mobilization from the lung, DMPS via inhalation was
given only once immediately after 1O9CdCl2 inhalation in rats.
It was found that lung and liver Cd was not altered; however,
kidney Cd was significantly increased in the treated group.
These data seem to suggest that Cd can be mobilized from the
lungwith DMPStreatment via inhalation, butfurther studies
are needed to clarify the influence of the treatment on Cd
burden ofthe kidneys.
Role ofMetallothionein in Ehrlich Cells: Cel-
lular and Chemical Studies. A. KRAKER, S.
KREZOSKI, G. BACHOWSKI, J. SCHNEIDER, C. F.
SHAW III, J. D. OTVOS, and D. H. PETERING, De-
partment of Chemistry, University of Wisconsin-
Milwaukee, Milwaukee, WI53201.
Ehrlich ascites tumor cells make constitutively Zn, Cu, Cd
binding protein with the properties of metallothionein (MT).
Diring host zinc deficiency, which inhibits Ehrlich cell prolif-
eration, zinc is specifically lost from MT. Readdition oflimited
amounts ofZn to the diet stimulates cell growth and division
without the return ofZn to MT. Results suggest that MT is a
metabolically active form of zinc in these cells which may
serve as an intermediate in the synthesis ofholo-Zn proteins.
In support of this view, MT is shown to be the predominant,
perhaps, exclusive source ofcytosolic Zn for the reconstitution
ofadded apocarbonic anhydrase. Besides the kinetic reactivity
of Zn in MT, the stability constants of zinc in its two-metal
clusters are in the range of 109-1010 mole. Both features
support the dynamic nature of the Zn in MT. To investigate
furtherthe role ofMT in Ehrlich cell proliferation, a cytotoxic
copper complex, 3-ethoxy-2-oxobutyraldehyde bis(thiosemi-
carbazonato)Cu(II), was reacted with these cells. The complex
is reduced and dissociated. In the range ofgrowth inhibition,
Cu(I) specifically displaces Zn from MT. Some copper binds to
high molecular weight protein. The reactivation ofDNA syn-
thesis and cell division follows the rapid loss of Cu from the
high molecular weight band and the subsequent return ofZn
to MT. These results and similar ones using Cd2 + in place of
copper are consistent with a key role of MT in cell prolifera-
tion, but do not exclude the possibility that other sites are
involved.
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